Key facts
- 4baseCare’s last known valuation is $840K (Feb 2019).
- It has raised $9.2M; the latest was Later Stage VC ($9.8M) in Jan 2026.
- Notable investors include MedTech Innovator, BIRAC, 77 Capital (India), Bangalore Bioinnovation Centre, Centre for Cellular And Molecular Platforms — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for 4baseCare
- ·The full record, as it builds
Funding rounds
No funding rounds for 4baseCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 4baseCare
Developer of genomics and digital health technology designed to fight cancer by transforming precision oncology in Asia. The company's technology is based on a unified and patient-centric ecosystem focusing on oncology, which is used in building a curated data resource of genetic and real-world clinical outcome information of cancer patients, enabling pharmaceutical companies to get assistance in precision and personalized cancer treatment for enhanced clinical outcomes.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2018
- Employees
- 185
- Website
- 4basecare.com/
- Ownership
- Privately Held (backing)
4baseCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 4baseCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 4baseCare in its N-PORT filings yet. We sweep new filings monthly.